Also listed on Horizon Pharma Rheumatology LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 15, 2041 · High confidence
20-year base term ends Nov 10, 2037
Held by Horizon Therapeutics USA, Inc.
Filed May 7, 2019 as application 16/347,900 · Granted Dec 16, 2025
Base term plus 1252 days of patent term adjustment (USPTO delay)
Today
2017
2041
Clock starts
Nov 10, 2017
Nov 10, 2017
Term ends
Apr 15, 2041
Apr 15, 2041
Granted
Dec 16, 2025
Dec 16, 2025
base term
patent term adjustment
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,252
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1252 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 10, 2017, when application PCT/US2017/061126, the earliest non-provisional in its chain, was filed (this one was filed May 7, 2019) | Nov 10, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1252 days, USPTO patent term adjustment record | Apr 15, 2041 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 15, 2041 | High confidence |
This family
| Application PCT/US2017/061126 | PCT application no patent term | no patent term |
| US 12,496,331 | this patent Apr 2041 | Apr 2041 |
| Application 19/389,928 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 26, 2021 Reel 56362, frame 331 | Kent, Jeffrey D; Lamoreaux, Brian | Horizon Pharma Rheumatology LLC | Assignment of Assignor's Interest |
| Sep 8, 2022 Reel 61396, frame 303 | Horizon Pharma Rheumatology LLC | Horizon Therapeutics USA, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2041
Term ends Apr 15, 2041. Maintenance fees still fall due before then
Note
The 1252 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
3
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.